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Summary
A 30 year old lady was seen by her family doctor during a 
busy clinic complaining of three episodes of left-sided headache 
over the previous four months.  The pain was usually throbbing 
in nature and it increased slowly in intensity over about an hour. 
She usually would have to lie down in a dark room to obtain some 
relief.  Nausea, vomiting and blurred vision usually accompanied 
the headache.  She had had headaches in the past but usually 
less severe and relieved by two to four paracetamol tablets per 
day.  She reported no family history of headaches and had not 
started any new medication.
What would you do and what issues does this consultation 
raise?
Introduction
Two main dilemmas usually come up when faced with a 
patient complaining of headaches:
• Deciding which headaches are benign and require no 
intervention and those which require immediate action.
• Differentiating between tension-type headache and 
migraine – two common causes of headache in family 
medicine.
Incidence
The BEACH program, a continuous national study of general 
practice activity in Australia, recorded 602100 encounters 
per 6021 GPs that is an average of 100 encounters per GP.  It 
showed that a patient gave headache as one of their reasons 
for encounter at a rate of 1.9 per 100 encounters.  Females are 
slightly more likely to present with headaches than males (2.0 
per 100 encounters for females and 1.7 per 100 encounters for 
males).  It also showed that GPs referred patients with headache 
at a higher rate than for other problems and were also more 
likely to order imaging especially CT scans (10.8 per 100).  The 
referral rate was at 11.4 per 100 encounters most commonly to 
a neurologist (2.8 per 100) or a physiotherapist (2.8 per 100).1
Differential  Diagnosis
The diagnosis given to patients regarding their headaches 
will influence the number of visits they will make to a GP. 
Patients with multiple headache diagnoses make more visits 
and those with combinations of headache diagnoses involving 
migraine are the most frequent visitors.2  It is thought important 
to give the correct diagnosis as quickly as possible to avoid 
frustration both to the patient and doctor.
Differentiating between primary headaches and secondary 
headaches is crucial.  The diagnosis of a primary headache 
requires that all other identifiable and probable conditions 
that can secondarily cause headache be excluded3 (Table 1). 
In taking the history and during examination one should look 
out for causes of secondary headache and where appropriate 
special investigations such as a CT scan should be carried out to 
exclude such causes.  In general practice, special investigations 
are not so easily available compared to the hospital setting so 
in certain cases the family doctor has to base his diagnosis on 
history and examination only and if these are normal but some 
doubt remains, review will be required.
Achieving the diagnosis
An important aspect when taking a history from a patient 
suffering from headaches is to let the patient talk with very 
little interruptions.  Even the words used to gather information 
from the patient are very important.  Open questions are more 
welcome than closed questions.  Allowing patients to speak 
about their illness, the impact of such illness on their life, 
and also about their beliefs will lead to a better diagnosis and 
compliance.
Proper history taking should include information about the 
onset of the headache, the severity, location and nature of the 
pain, the frequency, and duration of each attack if it is episodic 
in nature, premonitory and associated features, precipitating 
or relieving factors. A history of recent trauma should also 
be excluded amongst the other medical, psychiatric, family, 
social and drug histories. A thorough physical examination is 
important in as much as it serves to reassure the patient.
A history of episodic headaches is more usually in favour 
of a primary headache while a persistent headache may well 
be secondary to other pathology.  After making the distinction 
between a primary headache and a secondary headache one 
could use ‘blue flag’ features and ‘red flag’ features in the 
evaluation of secondary headaches to help stratify the urgency 
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of investigation and management.  Blue flag  features (Table 
2) indicate secondary headaches that do not require urgent 
investigation.  Red flag features require urgent attention 
(Table 3).3
In determining the likelihood of secondary headache, the 
most crucial clinical feature to elicit is the length of the history. 
Patients with a short history require prompt attention and 
may need quick investigation and management.  Patients with 
a longer history generally require time and patience rather 
than speed.4  In the former scenario patients should be referred 
urgently to the hospital accident and emergency department. 
In the latter scenario one has the “luxury” to review, to assess 
progression and perhaps effect of treatment and then decide 
on further management which may include referral, imaging 
or even certain blood tests such as ESR.
A recent British medical journal editorial by Peter Goadsby 
addressed the question of when and whether to scan patients 
with headache.  In the final part of his editorial Goadsby states 
that GP’s are good at managing an open access system to brain 
imaging (as is the case in Australia).5
Primary headache syndromes
Primary headaches can be divided into two categories 
depending on the frequency and attack duration (Table 4):
1. Episodic headaches
2. ‘Chronic daily’ headache
The treatment of the headache depends on the diagnosis. 
An important aspect in management is that the diagnosis is 
explained carefully.  It is important to take the beliefs the patient 
has regarding his headache into consideration and to discuss 
these with the patient.  The management and treatment should 
be agreed with the patient to avoid non-compliance.
Migraine
In the case scenario quoted in the beginning, the likely cause 
of the headache is migraine.  Two important aspects are to 
exclude intracranial pathology through a physical examination 
because of the side-locked location of the symptoms. The patient 
is also overusing analgesia which could lead to Medication 
Overuse Headache.
Migraine is usually defined (ICHD-II)4 as repeated attacks 
of headache lasting 4-72 hours that have these features:
A:  Normal physical examination
B:  No other reasonable cause for the headache
C:  At least two of the following:
• unilateral pain
• throbbing pain
• aggravation of pain by movement or physical exertion
• moderate or severe intensity of pain
D:  At least one of the following:
• Nausea or vomiting
• Phonopobia and photophobia
Table 1: Differential  diagnosis of headache3 
Headache
 
Primary headache Secondary headache
Primary episodic headache Headache secondary to disorders of the:
• Migraine • Skull (eg Paget’s disease)
• Episodic tension-type headache • Ears (eg otitis media or externa)
• Cluster headache and trigeminal autonomic cephalagia • Eyes (eg glaucoma, ocular strain)
  • Nose and nasal sinuses
  • Teeth
  • Cervical spine (eg cervical spondylosis)
  • Cranial nerves ( eg herpes zoster)
 
Primary frequent (chronic daily) headache Headache secondary to:
• Transformed migraine • Intracranial vascular disorders (eg cerebral haemorrhage)
• Chronic tension-type headache • Extracranial vascular disorders (eg cranial arteritis)
• New daily persistent headache • Disorders of intracranial pressure (eg raised intracranial
• Hemicrania continua  pressure or low cerebrospinal fluid pressure 
   eg post-lumbar puncture leak)
  • Intracranial infection
 
  Headache attributable to:
  • General infection (eg influenza)
  • Medication (eg vasodilators)
  • Hypertension
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There is sometimes a visual aura of flashing lights, zig-zag 
constellations, balls or filaments of light.  Many people with 
severe migraine find lying down in a dark room relieving.6
Why is migraine so important?
• It is common.  However data is conflicting, possibly due 
to under- or over-diagnosis of migraine.  A recent study 
quoted the prevalence of migraine as 25% in middle 
aged females.7  In addition it also affects children and 
is an important cause of school absenteeism.  In an 
observational study, the prevalence of migraine in school 
children was quoted to be 10.6%.8  The prevalence of 
migraine seems to rise from puberty and peaks during 
late twenties and early thirties, affecting more females 
than males.
• It is a disabling condition.  The World Health 
Organisation (WHO) considers that severe migraine can 
be as disabling as quadriplegia.4
• It increases the use of health services by patients.
• It has economic consequences to the individual and 
society.
• An issue which may come up during the consultation 
is the relation of migraine and stroke, possibly due to a 
similarity in presentation.  Evidence is conflicting, but 
a recent meta-analysis suggests that there might be an 
increased risk of stroke in migraine sufferers, which risk 
is particularly raised in female migraine patients who use 
the oral contraceptive pill.9
Differentiating between migraine 
and tension-type headache
Trying to differentiate between migraine and tension-type 
headache is important, due to the high prevalence of headache in 
the community.  Migraine is head pain with associated features 
while tension-type headache is a featureless head pain.  The most 
important distinguishing associated features of migraine are 
nausea and vomiting, photophobia and phonophobia, though 
admittedly tension-type headache may be associated with these 
latter symptoms, especially nausea.  Mild phonophobia and 
photophobia alone should not be used as exclusion criteria for 
tension-type headache.10  
The other differentiating factor is that migraine has 
biological signatures while tension-type headache does not. 
Common precipitating factors of migraine which may help in 
the differentiation include stress and menstruation, however 
the evidence base for such claims is not so strong according 
to a meta-analysis by Bandolier.6  There is also a tendency for 
migraine to run in families, so one should enquire about any 
family history of migraine.  In addition it may be useful to probe 
in the dietary habits of the patient and check for the relation of 
migraine to the intake of chocolate, cheese and aged wine.6
What do migraine patients want?
Patients want a treatment which acts quickly, relieves all 
pain, has little side effects and no recurrence.  They want their 
doctor to be willing to answer questions, to teach them how 
to treat attacks, to educate them about the causes and how to 
avoid attacks,  They want medical expertise and they also want 
understanding and empathy.
Table 2:  Blue flag headaches3
• Headache that is mainly occipital, but sometimes 
radiates to the temple, exacerbated by examination 
of neck mobility (cervicogenic headache or cervical 
spondylosis”
• Headache temporarily linked to whiplash injury of the 
neck
• Headache related to reading (eye strain)
• Headache clearly temporally linked to the ingestion of 
medication eg vasodilators
• Headaches associated with systemic viral illness eg 
influenza
Table 3:  Red flag headaches3
• Headache of sudden onset eg subarachnoid 
haemorrhage
• New onset headache in a specific setting eg metastases
• New headache that is persistently progressive
• Focal signs or symptoms (other than the typical visual 
or sensory aura of migraine) that precede or outlast 
the headache
• Headache with rash (may indicate meningococcal 
meningitis or Lyme disease)
• Persistent unilateral temple headache in adult life 
(may indicate cranial arteritis)
• Headache with a raised ESR (may be an indication 
of cranial arteritis, collagen disease, or systemic 
infection)
• Headache with papilloedema (raises the suspicion 
of raised intracranial pressure due to mass lesion or 
benign intracranial hypertension)
• Non-migraine headaches in pregnancy and post-
partum
• Headache clearly triggered by changes in position 
(may indicate low cerebrospinal fluid, for instance due 
to spontaneous CSF leak)
• Headaches associated with pressing visual disturbance 
(may indicate conditions such as glaucoma or optic 
neuritis)
• Change in the nature of the headache in a chronic 
setting
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Pathophysiology
In the 1960s and 1970s migraine was considered a vascular 
phenomenon and is still often referred to incorrectly as a 
vascular headache.4  However, brain imaging has suggested 
that the dorsolateral pons is pivotal in the phenotypic expression 
of migraine.
The clinical implication from this is that now doctors can 
be in a confident position to explain to their patients that their 
disorder is localised to the brain and it is normal for them to 
feel odd during attacks and have trouble concentrating.  It also 
opens up new paths for treatment.
Treatment
1. Acute treatment for migraine
Two approaches may be taken.
• Step up approach.  This means that treatment is 
progressively increased to more potent analgesics with 
each consultation for the same patient with the same 
complaint.  This may lead to patient dissatisfaction and 
shopping around by the patient.
• Stratified approach.  The severity of the attack is 
assessed and medication given proportionate to the 
symptoms with which the patient presents.  If the attack 
is not so severe one might start with simple analgesics.  
If the attack is severe one may consider using a triptan 
immediately.6
Triptans, which are selective 5-HT
IB/ID
 receptor agonists, 
were the main advance in migraine treatment during the 
latter part of the 20th century.  After sumatriptan, came 
zolmitriptan, naratriptan, rizatriptan, almotriptan, eletriptan 
and frovatriptan. Donitriptan has now finished preclinical 
development.  Ergotamine has now few indications.4  These 
drugs come in various formulations (tablets and sprays) which 
is helpful in the acute setting.
Paracetamol, aspirin and NSAIDs (non-steroidal anti-
inflammatory drugs) are commonly used to relieve pain also. 
Metoclopromide or domperidone should be considered if nausea 
is a prominent feature.
2. Preventive treatment in migraine
 Approximately 5% of migraine sufferers will need 
preventive treatment due to the disabling nature of 
their headaches.11  On average, two-thirds of patients 
will have a 50% reduction in headache frequency with 
most preventive drugs.4  Preventive drugs include beta-
blockers, antidepressants, calcium-channel blockers, 
anticonvulsants and some other agents such as lisinopril 
and cadesartan.  The evidence base for these treatment 
varies, and whereas in the case of amitryptiline, 
propranolol and sodium valproate the evidence is 
robust, there is conflicting evidence as regards the use 
of verapamil.9  In fact the latter is considered by BASH 
(British Association for the Study of Headache) to have 
little or uncertain efficacy.13  Recent and promising 
additions to this pharmacological armamentarium 
include lisinopril, candesartan and topiramate.
Beta-blockers
Propranolol is one of the most commonly prescribed drugs 
for migraine prophylaxis.  From various studies it was found 
that propanolol is more effective than placebo in the short-term 
treatment of migraine.  Propranolol is particularly indicated 
in patients who suffer from migraine and recurrent anxiety-
induced palpitations.  Evidence on long term effects is lacking.14 
Regarding other beta-blockers such as atenolol, metoprolol 
and nadolol there is limited evidence to support their use in 
migraine prophylaxis.12
Antidepressants
Amitriptyline is a first-line agent for migraine prophlaxis and 
is the only antidepressant with constant evidence supporting its 
effectiveness in migraine prophylaxis.12  Selective serotonin re-
uptake inhibitors (SSRIs) have been evaluated for the prevention 
of migraine and also tension-type headache but evidence is not 
so robust so far.15  Venlafaxine is occasionally used as second 
line therapy but evidence base is poor.
Anticonvulsants
Anticonvulsant drugs seem to be useful in clinical practice for 
the prophylaxis of migraine.  They appear to be both effective in 
reducing migraine frequency and are reasonably well tolerated. 
Neither clonazepam nor lamotrigine was superior to placebo. 
Relatively few robust trials are available for agents other than 
sodium valproate/divalproex sodium.  Two recently published 
and large trials of topiramate demonstrated reasonable 
efficacy.16  Topiramate (Topamax®) has been approved for the 
prevention of migraine.17
Shrader et al have shown that the angiotensin converting 
enzyme inhibitor, lisinopril, has a clinically important 
prophylactic effect in migraine.18
At present no one can reliably predict who are the patients 
that will respond to a particular medication.  On the other hand 
individual patients were shown to have dramatic responses 
to various medications.  A hands-on approach to dealing 
with this issue is to be guided by existing co-morbities and 
patient characteristics in prescribing preventive treatment. 
For example, a female with hypertension would preferably 
be prescribed verapamil; a male patient who has an obsessive 
personality trait would benefit more from amitryptiline.
3. Complementary and alternative treatment
Most trials on complementary or alternative treatment 
indicate that these do not work.6
• Acupuncture -  high quality trials showed that it is not 
effective.
• Chiropractice – limited evidence on how effective it is.
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• Feverfew for migraine prophylaxis – some evidence 
suggests it works but more data is needed.
• Homeopathy for prophylaxis – no difference between 
homeopathy and placebo.
• Relaxation and biofeedback in paediatric headache 
– Probably as effective as other non-pharmacological 
interventions.
Conclusion
Doctors in general practice frequently encounter headache 
as a presenting complaint.  Sometimes it will frustrate the family 
doctor especially if time is pressing and the waiting room is full 
of patients.  Listening to the patient will give most information. 
Coupled with a good physical examination, the GP should be in 
a position to answer the two most important questions: is this a 
benign headache or one with sinister pathology?  Is it migraine 
or tension-type headache?  Adequate history taking allows 
appropriate gauging of severity of symptoms so that treatment 
can be tailored accordingly.
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Table 4:  Clinical features 
  of primary headache syndromes3 
Episodic  Headache
 
• Migraine 
• Female predilection
• Often commences in adolescence; presence of family 
history
• Associated visual, sensory, motor or cortical 
symptoms
• Unilateral throbbing headache
• Associated gastrointestinal symptoms of nausea and 
vomiting
• Associated photo- and phono-phobia
• Usually lasts 4-72 hours
• Often recurrent, predictable triggers
• Tension-type headache 
• Female predilection not so prominent as in migraine
• Often begins in young adulthood or later
• Described as ‘tight band-like pressing headache
• No features of gastrointestinal disturbance, photo- 
or phono-phobia; no aura
• Unusually not as incapacitating as migraine or 
cluster headache
• Usually lasts 30minutes to 7 days
• Cluster headache 
• Male predilection
• Severe, often excruciating pain; Unilateral with 
seldom side shift
• Location of pain typically behind the affected eye
• Usually lasts 15-180 minutes
• Ipsilateral autonomous phenomena
• Seldom has triggers (except for alcohol during a 
cluster)
 
Chronic Daily Headache 
• Chronic Migraine 
•  Headache on more than 15 days per month 
•  History of migraine with gradual build-up of 
headache frequency until the headache becomes 
daily 
• Features of migraine present 
• Rarely, the migrainous features disappear, and only 
a chronic daily non-specific headache is left
• Chronic Tension-Type Headache 
• Tension-type headache whose frequency increases 
until it becomes a daily headache 
• Daily dull bilateral headache characterised by a 
pressing or gripping or band-like headache with no 
migrainous features 
